Matching slides 303,780
Current window 201,841-201,870
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

201,841-201,870 of 303,780

filter-aware
38
The chart displays mean values with SEM error bars for various THC doses and ANEB-001 treatment groups.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
39
The slide displays PK data on both linear and log scales to demonstrate dose-related exposure and half-life characteristics.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
40
The slide compares six different treatment arms across two scales to demonstrate dose-related exposure.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
41
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
42
Clinical trial update slide.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
43
The slide outlines the methodology for a clinical study, including target sample size (120) and duration (12 months).Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
44
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
45
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
46
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
47
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
48
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
49
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
50
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
51
The slide uses a linear process flow with icons representing each stage.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
52
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
53
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
01
Slide 1
Includes company logo, date, and ticker symbol.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
02
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style chart to show clinical trial progress for multiple assets.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style timeline to track clinical trial progress (P2 data, enrollment, FPI) against calendar years.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Team1 hit
07
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
08
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
09
The slide uses a comparative framework to position the drug as a superior alternative to existing checkpoint inhibitors.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a diagram of an antibody to map specific functional regions to their biological mechanisms.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
Uses two 2x2 matrices to position competitors relative to Apexigen.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
14
The chart is a classic 'spider plot' used in oncology to track individual patient tumor burden over time.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
15
Spider plot (swimmer plot variant) showing individual patient responses over time.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a before-and-after medical imaging comparison to validate clinical efficacy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit